• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Recipharm, Adroit Science collaborate to expand service offering

Recipharm, Adroit Science collaborate to expand service offering

March 26, 2015
CenterWatch Staff

Two Swedish companies, Recipharm, a contract development and manufacturing organization (CDMO), and Adroit Science, a provider of laboratory and consultancy services, have formed a new strategic collaboration.

Adroit Science will support Recipharm's pharmaceutical development with solid state characterization services. By combining experience in formulation development, API development, chemical analysis and solid state characterization, both the speed and cost of development can be reduced while, at the same time, quality is improved. 

Carl-Johan Spak, executive vice president, development and technology at Recipharm, said, "With the addition of development services from Adroit, we will have a very competitive offering, which will help our customers to progress their projects in a highly efficient way.  Adroit Science has established itself as one of the leading providers of solid state characterization services in Northern Europe.”

"Adroit Science and Recipharm already have cooperated in a number of successful projects, and this formal partnership marks the logical next step in the mutual development of our strategic relationship," said Hans Gredeby, CEO of Adroit Science.

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing